A quantitative analysis confirmed that the CHL-GCS-IO NPs group exhibited the lowest CXCL12 levels, significantly lower than those in the other groups, highlighting the role of CHL-GCS-IO NPs in inhibiting factors that promote tumor progression and metastasis. Here, CXCL12 is linked to neoplasm.